• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Seeing the Forest for the (Arterial) Tree: Vascular Pruning and the Chronic Obstructive Pulmonary Disease Pulmonary Vascular Phenotype.

作者信息

Weatherald Jason, Montani David, Humbert Marc

机构信息

1Department of MedicineUniversity of CalgaryCalgary, Canada.

2Libin Cardiovascular Institute of AlbertaCalgary, Canada.

出版信息

Am J Respir Crit Care Med. 2019 Aug 15;200(4):406-408. doi: 10.1164/rccm.201901-0248ED.

DOI:10.1164/rccm.201901-0248ED
PMID:30908925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6701042/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0764/6701042/76365cd15991/rccm.201901-0248ED_f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0764/6701042/76365cd15991/rccm.201901-0248ED_f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0764/6701042/76365cd15991/rccm.201901-0248ED_f1.jpg

相似文献

1
Seeing the Forest for the (Arterial) Tree: Vascular Pruning and the Chronic Obstructive Pulmonary Disease Pulmonary Vascular Phenotype.透过（动脉）树木见森林：血管修剪与慢性阻塞性肺疾病的肺血管表型
Am J Respir Crit Care Med. 2019 Aug 15;200(4):406-408. doi: 10.1164/rccm.201901-0248ED.
2
Cardiovascular consequences of pulmonary hypertension.肺动脉高压的心血管后果。
Nurs Clin North Am. 2008 Mar;43(1):17-36; v. doi: 10.1016/j.cnur.2007.11.001.
3
Diverse forms of pulmonary hypertension remodel the arterial tree to a high shear phenotype.多种形式的肺动脉高压会将动脉树重塑为高剪切力表型。
Am J Physiol Heart Circ Physiol. 2014 Aug 1;307(3):H405-17. doi: 10.1152/ajpheart.00144.2014. Epub 2014 May 23.
4
[Pulmonary vascular remodeling is prior to the increase in pulmonary hypertension of chronic obstructive pulmonary disease].[肺血管重塑先于慢性阻塞性肺疾病肺动脉高压的升高]
Zhonghua Jie He He Hu Xi Za Zhi. 2018 Jun 12;41(6):478-484. doi: 10.3760/cma.j.issn.1001-0939.2018.06.009.
5
Pulmonary hypertension in chronic lung diseases.慢性肺部疾病相关肺动脉高压。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036.
6
[The treatment of pulmonary arterial hypertension associated with chronic obstructive pulmonary disease makes sense - pro].
Dtsch Med Wochenschr. 2008 Apr;133(14):720. doi: 10.1055/s-2008-1067314.
7
Updated Perspectives on Pulmonary Hypertension in COPD.COPD 相关肺动脉高压的最新观点。
Int J Chron Obstruct Pulmon Dis. 2020 Jun 9;15:1315-1324. doi: 10.2147/COPD.S211841. eCollection 2020.
8
Airway Epithelial Genomic Signatures in Steroid-Resistant COPD; Role for SMAD3 in Vascular Remodeling in Pulmonary Hypertension; Regulation of Lung Endothelial Cell Function by VEGFR3.类固醇抵抗性慢性阻塞性肺疾病中的气道上皮基因组特征；SMAD3在肺动脉高压血管重塑中的作用；VEGFR3对肺内皮细胞功能的调节。
Am J Respir Cell Mol Biol. 2019 Sep;61(3):392-394. doi: 10.1165/rcmb.2019-0075RO.
9
The use of iloprost in the treatment of 'out of proportion' pulmonary hypertension in chronic obstructive pulmonary disease.伊洛前列素在治疗慢性阻塞性肺疾病中“不成比例”的肺动脉高压中的应用。
Int J Clin Pharm. 2013 Jun;35(3):313-5. doi: 10.1007/s11096-013-9762-3. Epub 2013 Apr 3.
10
Pulmonary arterial lesions in explanted lungs after transplantation correlate with severity of pulmonary hypertension in chronic obstructive pulmonary disease.移植肺中肺动脉病变与慢性阻塞性肺疾病肺动脉高压的严重程度相关。
J Heart Lung Transplant. 2013 Mar;32(3):347-54. doi: 10.1016/j.healun.2012.11.014. Epub 2012 Dec 21.

引用本文的文献

1
Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV decline: results from COPDGene and SPIROMICS.用于筛查有FEV下降风险的高危、轻度和中度慢性阻塞性肺疾病（COPD）患者的机器学习：来自慢性阻塞性肺疾病基因研究（COPDGene）和慢性阻塞性肺疾病生物标志物研究（SPIROMICS）的结果
Front Physiol. 2023 Apr 21;14:1144192. doi: 10.3389/fphys.2023.1144192. eCollection 2023.
2
Endotyping COPD: hypoxia-inducible factor-2 as a molecular "switch" between the vascular and airway phenotypes?表型 COPD 研究：缺氧诱导因子-2 作为血管表型和气道表型之间的分子“开关”？
Eur Respir Rev. 2023 Jan 11;32(167). doi: 10.1183/16000617.0173-2022. Print 2023 Mar 31.
3

本文引用的文献

1
Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study.动脉血管退化、右心室大小与慢性阻塞性肺疾病的临床转归。一项纵向观察性研究。
Am J Respir Crit Care Med. 2019 Aug 15;200(4):454-461. doi: 10.1164/rccm.201811-2063OC.
2
Pulmonary hypertension in chronic lung disease and hypoxia.慢性肺部疾病与低氧血症相关性肺动脉高压
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01914-2018. Print 2019 Jan.
3
Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype?
Management of Pulmonary Hypertension Due to Chronic Lung Disease.
慢性肺病相关肺动脉高压的管理。
Methodist Debakey Cardiovasc J. 2021 Jul 1;17(2):124-133. doi: 10.14797/ZKUT3813. eCollection 2021.
4
The effects of genetic deletion of Macrophage migration inhibitory factor on the chronically hypoxic pulmonary circulation.巨噬细胞移动抑制因子基因缺失对慢性低氧肺循环的影响。
Pulm Circ. 2020 Oct 26;10(4):2045894020941352. doi: 10.1177/2045894020941352. eCollection 2020 Oct-Dec.
5
Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?肺动脉高压中的肺血管阻力：关键因素？
Am J Respir Crit Care Med. 2021 Feb 15;203(4):524-525. doi: 10.1164/rccm.202009-3664LE.
6
Update in Chronic Obstructive Pulmonary Disease 2019.2019年慢性阻塞性肺疾病的进展
Am J Respir Crit Care Med. 2020 Aug 1;202(3):348-355. doi: 10.1164/rccm.202002-0370UP.
7
Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.2019年肺血管疾病与右心室功能障碍的进展
Am J Respir Crit Care Med. 2020 Jul 1;202(1):22-28. doi: 10.1164/rccm.202003-0576UP.
慢性阻塞性肺疾病中的肺血管受累。是否存在肺血管表型？
Am J Respir Crit Care Med. 2018 Oct 15;198(8):1000-1011. doi: 10.1164/rccm.201801-0095PP.
4
More on idiopathic pulmonary arterial hypertension with a low diffusing capacity.更多关于伴有低弥散能力的特发性肺动脉高压的内容。
Eur Respir J. 2017 Aug 3;50(2). doi: 10.1183/13993003.00354-2017. Print 2017 Aug.
5
Is there a vanishing pulmonary capillary syndrome?是否存在肺毛细血管消失综合征？
Lancet Respir Med. 2017 Sep;5(9):676-678. doi: 10.1016/S2213-2600(17)30291-6. Epub 2017 Jul 19.
6
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015 ESC/ERS 肺动脉高压诊断与治疗指南：欧洲心脏病学会（ESC）和欧洲呼吸学会（ERS）肺动脉高压诊断与治疗工作组制定：该指南得到了欧洲儿科和先天性心脏病协会（AEPC）以及国际心肺移植学会（ISHLT）的认可。
Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29.
7
Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses.特发性肺动脉高压患者的弥散能力严重降低：患者特征和治疗反应。
Eur Respir J. 2013 Dec;42(6):1575-85. doi: 10.1183/09031936.00184412. Epub 2013 Aug 15.
8
Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease.与终末期慢性阻塞性肺疾病相关的肺动脉高压的患病率、预测因素和生存率。
J Heart Lung Transplant. 2012 Apr;31(4):373-80. doi: 10.1016/j.healun.2011.11.020. Epub 2012 Jan 9.
9
Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice.诱导型一氧化氮合酶抑制逆转了香烟烟雾引起的小鼠肺气肿和肺动脉高压。
Cell. 2011 Oct 14;147(2):293-305. doi: 10.1016/j.cell.2011.08.035.
10
Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers.循环内皮微颗粒作为吸烟人群早期肺损伤的衡量指标。
Am J Respir Crit Care Med. 2011 Jul 15;184(2):224-32. doi: 10.1164/rccm.201012-2061OC. Epub 2011 Mar 11.